Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-11-17–present
Equibles does not estimate personal net worth.
Get an email with a short summary when Rockwell Medical, Inc. publishes a filing, an earnings call transcript or a press release.
Get RMTI alertsJoseph H. Dawson is recorded as Board Member at Rockwell Medical, Inc. (RMTI) since November 17, 2025. Rockwell Medical, Inc. reported in an 8-K filed November 18, 2025 that Joseph H. Dawson was appointed Nominating and Corporate Governance Committee, effective November 17, 2025. Rockwell Medical, Inc. reported in an 8-K filed November 18, 2025 that Joseph H. Dawson was appointed Class II director, effective November 17, 2025. Rockwell Medical, Inc. is classified in the Drug Manufacturers - Specialty & Generic industry within the Healthcare sector. Other leadership on record at Rockwell Medical, Inc. includes Mark Strobeck (CEO and Board Member), Mark Strobeck, Ph.D. (CEO and Board Member), Russell Ellison (CEO and Board Member) and 7 others.
“Mr. Dawson has also been appointed to serve on the Nominating and Corporate Governance Committee of the Board (the "Nominating Committee"), effective immediately.”
“On November 17, 2025, the Board appointed Joseph H. Dawson to the Board as a Class II director to serve until the Company's 2026 Annual Meeting of Stockholders and until his successor is duly elected and qualified, effective immediately.”
2025-11-17–present
SEC 8-K
2025-11-17–present
Drug Manufacturers - Specialty & Generic · Healthcare
Board Member
2025-11-17–present